Literature DB >> 21506637

Virus-like particles: innate immune stimulators.

Ramadevi Raghunandan.   

Abstract

Mesh：

Substances：

Year:  2011        PMID： 21506637     DOI： 10.1586/erv.11.37

Source DB:  PubMed          Journal:  Expert Rev Vaccines        ISSN： 1476-0584            Impact factor:   5.217


× No keyword cloud information.
  9 in total

1.  Insert engineering and solubility screening improves recovery of virus-like particle subunits displaying hydrophobic epitopes.

Authors:  R S Abidin; L H L Lua; A P J Middelberg; F Sainsbury
Journal:  Protein Sci       Date:  2015-10-07       Impact factor: 6.725

2.  An enhanced heterologous virus-like particle for human papillomavirus type 16 tumour immunotherapy.

Authors:  Khairunadwa Jemon; Vivienne Young; Michelle Wilson; Sara McKee; Vernon Ward; Margaret Baird; Sarah Young; Merilyn Hibma
Journal:  PLoS One       Date:  2013-06-14       Impact factor: 3.240

3.  Incorporation of membrane-anchored flagellin or Escherichia coli heat-labile enterotoxin B subunit enhances the immunogenicity of rabies virus-like particles in mice and dogs.

Authors:  Yinglin Qi; Hongtao Kang; Xuexing Zheng; Hualei Wang; Yuwei Gao; Songtao Yang; Xianzhu Xia
Journal:  Front Microbiol       Date:  2015-03-03       Impact factor: 5.640

Review 4.  Virus-Like Particles as an Immunogenic Platform for Cancer Vaccines.

Authors:  Jerri C Caldeira; Michael Perrine; Federica Pericle; Federica Cavallo
Journal:  Viruses       Date:  2020-04-27       Impact factor: 5.048

5.  Self-assembly into virus-like particles of the recombinant capsid protein of porcine circovirus type 3 and its application on antibodies detection.

Authors:  Yu Wang; Gang Wang; Wei-Tong Duan; Ming-Xia Sun; Meng-Hang Wang; Shang-Hui Wang; Xue-Hui Cai; Ya-Bin Tu
Journal:  AMB Express       Date:  2020-01-07       Impact factor: 3.298

6.  Rational design of novel fusion rabies glycoproteins displaying a major antigenic site of foot-and-mouth disease virus for vaccine applications.

Authors:  Ernesto Garay; Diego Fontana; Lautaro Leschiutta; Ricardo Kratje; Claudio Prieto
Journal:  Appl Microbiol Biotechnol       Date:  2021-12-31       Impact factor: 4.813

Review 7.  SARS-CoV-2 reinfection and implications for vaccine development.

Authors:  Firzan Nainu; Rufika Shari Abidin; Muh Akbar Bahar; Andri Frediansyah; Talha Bin Emran; Ali A Rabaan; Kuldeep Dhama; Harapan Harapan
Journal:  Hum Vaccin Immunother       Date:  2020-12-01       Impact factor: 3.452

8.  Chimeric rabies virus-like particles containing membrane-anchored GM-CSF enhances the immune response against rabies virus.

Authors:  Hongtao Kang; Yinglin Qi; Hualei Wang; Xuexing Zheng; Yuwei Gao; Nan Li; Songtao Yang; Xianzhu Xia
Journal:  Viruses       Date:  2015-03-11       Impact factor: 5.048

Review 9.  Design Concepts of Virus-Like Particle-Based HIV-1 Vaccines.

Authors:  Chun-Wei Chen; Narcís Saubi; Joan Joseph-Munné
Journal:  Front Immunol       Date:  2020-09-30       Impact factor: 7.561
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.